Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

1.

Improved Outcomes Owing to High-intensity Focused Ultrasound Devices Version-up for the Treatment of Patients with Localized Prostate Cancer.

Uchida T, Tomonaga T, Kim H, Nakano M, Shoji S, Nagata Y, Terachi T.

J Urol. 2014 Jul 28. pii: S0022-5347(14)04047-6. doi: 10.1016/j.juro.2014.07.096. [Epub ahead of print]

PMID:
25079940
[PubMed - as supplied by publisher]
2.

Time-dependent change of blood flow in the prostate treated with high-intensity focused ultrasound.

Shoji S, Tonooka A, Hashimoto A, Nakamoto M, Tomonaga T, Nakano M, Sato H, Terachi T, Koike J, Uchida T.

Int J Urol. 2014 Jun 25. doi: 10.1111/iju.12515. [Epub ahead of print]

PMID:
24964077
[PubMed - as supplied by publisher]
3.

Loss of periplakin expression is associated with pathological stage and cancer-specific survival in patients with urothelial carcinoma of the urinary bladder.

Matsumoto K, Ikeda M, Sato Y, Kuruma H, Kamata Y, Nishimori T, Tomonaga T, Nomura F, Egawa S, Iwamura M.

Biomed Res. 2014;35(3):201-6.

PMID:
24942859
[PubMed - in process]
Free Article
4.

Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.

Matsushita K, Shimada H, Ueda Y, Inoue M, Hasegawa M, Tomonaga T, Matsubara H, Nomura F.

World J Gastroenterol. 2014 Apr 21;20(15):4316-28. doi: 10.3748/wjg.v20.i15.4316.

PMID:
24764668
[PubMed - in process]
Free PMC Article
5.

Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.

Kume H, Muraoka S, Kuga T, Adachi J, Narumi R, Watanabe S, Kuwano M, Kodera Y, Matsushita K, Fukuoka J, Masuda T, Ishihama Y, Matsubara H, Nomura F, Tomonaga T.

Mol Cell Proteomics. 2014 Jun;13(6):1471-84. doi: 10.1074/mcp.M113.037093. Epub 2014 Mar 31.

PMID:
24687888
[PubMed - in process]
6.

Lamin B2 prevents chromosome instability by ensuring proper mitotic chromosome segregation.

Kuga T, Nie H, Kazami T, Satoh M, Matsushita K, Nomura F, Maeshima K, Nakayama Y, Tomonaga T.

Oncogenesis. 2014 Mar 17;3:e94. doi: 10.1038/oncsis.2014.6.

PMID:
24637494
[PubMed]
Free PMC Article
7.

The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers.

Oji Y, Tatsumi N, Fukuda M, Nakatsuka S, Aoyagi S, Hirata E, Nanchi I, Fujiki F, Nakajima H, Yamamoto Y, Shibata S, Nakamura M, Hasegawa K, Takagi S, Fukuda I, Hoshikawa T, Murakami Y, Mori M, Inoue M, Naka T, Tomonaga T, Shimizu Y, Nakagawa M, Hasegawa J, Nezu R, Inohara H, Izumoto S, Nonomura N, Yoshimine T, Okumura M, Morii E, Maeda H, Nishida S, Hosen N, Tsuboi A, Oka Y, Sugiyama H.

Int J Oncol. 2014 May;44(5):1461-9. doi: 10.3892/ijo.2014.2318. Epub 2014 Mar 4.

PMID:
24589652
[PubMed - in process]
Free PMC Article
8.

Selective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique.

Yamaguchi S, Zhang B, Tomonaga T, Seino U, Kanagawa A, Segawa M, Nagasaka H, Suzuki A, Miida T, Yamada S, Sasaguri Y, Doi T, Saku K, Okazaki M, Tochino Y, Hirano K.

J Lipid Res. 2014 May;55(5):905-18. doi: 10.1194/jlr.M047761. Epub 2014 Feb 25.

PMID:
24569139
[PubMed - in process]
9.

Quantitative proteomic analysis of cultured skin fibroblast cells derived from patients with triglyceride deposit cardiomyovasculopathy.

Hara Y, Kawasaki N, Hirano K, Hashimoto Y, Adachi J, Watanabe S, Tomonaga T.

Orphanet J Rare Dis. 2013 Dec 21;8:197. doi: 10.1186/1750-1172-8-197.

PMID:
24360150
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Absolute Quantitation of Low Abundance Plasma APL1β peptides at Sub-fmol/mL Level by SRM/MRM without Immunoaffinity Enrichment.

Sano S, Tagami S, Hashimoto Y, Yoshizawa-Kumagaye K, Tsunemi M, Okochi M, Tomonaga T.

J Proteome Res. 2014 Feb 7;13(2):1012-20. doi: 10.1021/pr4010103. Epub 2013 Dec 26.

PMID:
24354742
[PubMed - in process]
11.

Increased concentrations of apo A-I and apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry.

Liu Y, Sogawa K, Sunaga M, Umemura H, Satoh M, Kazami T, Yoshikawa M, Tomonaga T, Yokosuka O, Nomura F.

Am J Clin Pathol. 2014 Jan;141(1):52-61. doi: 10.1309/AJCPBLFBNAP6N2UN.

PMID:
24343737
[PubMed - indexed for MEDLINE]
12.

Formation of long and winding nuclear F-actin bundles by nuclear c-Abl tyrosine kinase.

Aoyama K, Yuki R, Horiike Y, Kubota S, Yamaguchi N, Morii M, Ishibashi K, Nakayama Y, Kuga T, Hashimoto Y, Tomonaga T, Yamaguchi N.

Exp Cell Res. 2013 Dec 10;319(20):3251-68. doi: 10.1016/j.yexcr.2013.09.003. Epub 2013 Sep 13.

PMID:
24041959
[PubMed - indexed for MEDLINE]
13.

Transition of serum alkaline phosphatase isoenzymes during liver regeneration in humans.

Muraoka I, Soyama A, Takatsuki M, Tomonaga T, Hidaka M, Kanematsu T, Eguchi S.

Hepatogastroenterology. 2013 Sep;60(126):1476-8. doi: 10.5754/hge11097.

PMID:
23933940
[PubMed - indexed for MEDLINE]
14.

A novel mechanism of keratin cytoskeleton organization through casein kinase Iα and FAM83H in colorectal cancer.

Kuga T, Kume H, Kawasaki N, Sato M, Adachi J, Shiromizu T, Hoshino I, Nishimori T, Matsubara H, Tomonaga T.

J Cell Sci. 2013 Oct 15;126(Pt 20):4721-31. doi: 10.1242/jcs.129684. Epub 2013 Jul 31.

PMID:
23902688
[PubMed - indexed for MEDLINE]
Free Article
15.

Phosphorylation of KRAB-associated protein 1 (KAP1) at Tyr-449, Tyr-458, and Tyr-517 by nuclear tyrosine kinases inhibits the association of KAP1 and heterochromatin protein 1α (HP1α) with heterochromatin.

Kubota S, Fukumoto Y, Aoyama K, Ishibashi K, Yuki R, Morinaga T, Honda T, Yamaguchi N, Kuga T, Tomonaga T, Yamaguchi N.

J Biol Chem. 2013 Jun 14;288(24):17871-83. doi: 10.1074/jbc.M112.437756. Epub 2013 May 4.

PMID:
23645696
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.

Matsushita K, Tamura M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Levens D, He L, Liu J, Yoshida M, Nomura F.

Mol Cancer Res. 2013 Jul;11(7):689-98. doi: 10.1158/1541-7786.MCR-12-0673. Epub 2013 Apr 17.

PMID:
23594796
[PubMed - indexed for MEDLINE]
Free Article
17.

Prohibitin and its rapidly emerging role as a biomarker of systemic malignancies-reply.

Guo F, Hiroshima K, Wu D, Satoh M, Abulazi M, Nomura F, Yoshino I, Tomonaga T, Nakatani Y.

Hum Pathol. 2013 Apr;44(4):679-80. doi: 10.1016/j.humpath.2012.12.008. No abstract available.

PMID:
23506708
[PubMed - indexed for MEDLINE]
18.

Transplanted fibroblast cell sheets promote migration of hepatic progenitor cells in the incised host liver in allogeneic rat model.

Muraoka I, Takatsuki M, Sakai Y, Tomonaga T, Soyama A, Hidaka M, Hishikawa Y, Koji T, Utoh R, Ohashi K, Okano T, Kanematsu T, Eguchi S.

J Tissue Eng Regen Med. 2013 Mar 12. doi: 10.1002/term.1718. [Epub ahead of print]

PMID:
23495245
[PubMed - as supplied by publisher]
19.

Curcumin improves the survival rate after a massive hepatectomy in rats.

Inokuma T, Yamanouchi K, Tomonaga T, Miyazaki K, Hamasaki K, Hidaka M, Takatsuki M, Kanematsu T, Eguchi S.

Hepatogastroenterology. 2012 Oct;59(119):2243-7. doi: 10.5754/hge10650.

PMID:
23435139
[PubMed - indexed for MEDLINE]
20.

Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus.

Sogawa K, Noda K, Umemura H, Seimiya M, Kuga T, Tomonaga T, Nishimura M, Kanai F, Imazeki F, Takizawa H, Yoneda M, Nakajima A, Tsutsumi M, Yokosuka O, Nomura F.

Proteomics Clin Appl. 2013 Jun;7(5-6):424-31. doi: 10.1002/prca.201200094. Epub 2013 May 17.

PMID:
23382097
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk